Literature DB >> 2115026

Leukotriene and hydroxyeicosatetraenoic acid generation elicited by low doses of Escherichia coli hemolysin in rabbit lungs.

F Grimminger1, D Walmrath, R G Birkemeyer, S Bhakdi, W Seeger.   

Abstract

Low doses of Escherichia coli hemolysin cause thromboxane-mediated hypertension and vascular leakage in blood-free perfused rabbit lungs (W. Seeger, H. Walter, N. Suttorp, M. Muhly, and S. Bhakdi, J. Clin. Invest. 84:220-227, 1989). The recirculating buffer medium and bronchoalveolar lavage fluid from lungs exposed to hemolysin (2.5 hemolytic units per ml) in the presence of cyclooxygenase inhibitor were analyzed for leukotrienes (LTs) and hydroxyeicosatetraenoic acids (HETEs) by reverse-phase and straight-phase high-pressure liquid chromatographic techniques combined with UV spectrum analysis and post-high-pressure liquid chromatography radioimmunoassay. A rapid release of large amounts of cysteinyl-LTs and leukotriene B4 (LTB4) into the intravascular space was noted (total sum, approximately 4 to 5 micrograms). Similar quantities have hitherto been elicited only by high concentrations of the artificial calcium ionophore A 23187. Moreover, a marked liberation of 5-HETE and 12-hydroxyheptadecatrienoic acid into the buffer medium occurred, whereas LTB4 represented the predominant compound in the lavage fluid. The hemolysin-induced burst of LT and HETE generation preceded the onset of vascular leakage. The outstanding capacity of E. coli hemolysin to produce the liberation of potent lipid mediators is probably relevant to the pathways of vascular injury and amplification of inflammatory events during severe infection with hemolytic E. coli strains.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115026      PMCID: PMC258869          DOI: 10.1128/iai.58.8.2659-2663.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Thromboxane-mediated hypertension and vascular leakage evoked by low doses of Escherichia coli hemolysin in rabbit lungs.

Authors:  W Seeger; H Walter; N Suttorp; M Muhly; S Bhakdi
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

2.  Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung.

Authors:  T R Martin; L C Altman; R K Albert; W R Henderson
Journal:  Am Rev Respir Dis       Date:  1984-01

3.  Properties of leukotriene B4 20-hydroxylase from polymorphonuclear leukocytes.

Authors:  W S Powell
Journal:  J Biol Chem       Date:  1984-03-10       Impact factor: 5.157

4.  Inhibition of cyclooxygenase production does not prevent arachidonate from increasing extravascular lung water and albumin in an isolated dog lung.

Authors:  M R Littner; G M Kazmi; F D Lott
Journal:  Prostaglandins Leukot Med       Date:  1984-07

5.  Metabolism of leukotrienes B4 and C4 in the isolated perfused rat lung.

Authors:  T W Harper; J Y Westcott; N Voelkel; R C Murphy
Journal:  J Biol Chem       Date:  1984-12-10       Impact factor: 5.157

6.  In vivo and in vitro effects of endotoxin on prostaglandin release from rat lung.

Authors:  N Feuerstein; P W Ramwell
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

7.  Characterization of Escherichia coli hemolysins conferring quantitative differences in virulence.

Authors:  R A Welch; S Falkow
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

Review 8.  Metabolites of arachidonic acid in experimental lung vascular injury.

Authors:  K L Brigham
Journal:  Fed Proc       Date:  1985-01

9.  Increased pulmonary vascular resistance and permeability due to arachidonate metabolism in isolated rabbit lungs.

Authors:  W Seeger; H Wolf; G Stähler; H Neuhof; L Róka
Journal:  Prostaglandins       Date:  1982-02

10.  Staphylococcal alpha-toxin-induced PGI2 production in endothelial cells: role of calcium.

Authors:  N Suttorp; W Seeger; E Dewein; S Bhakdi; L Roka
Journal:  Am J Physiol       Date:  1985-01
View more
  11 in total

1.  Characterization of monoclonal antibodies against alpha-hemolysin of Escherichia coli.

Authors:  R L Oropeza-Wekerle; P Kern; D Sun; S Muller; J P Briand; W Goebel
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

Review 2.  The different hemolysins of Escherichia coli.

Authors:  L Beutin
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

Review 3.  Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection.

Authors:  S Bhakdi; F Grimminger; N Suttorp; D Walmrath; W Seeger
Journal:  Med Microbiol Immunol       Date:  1994-07       Impact factor: 3.402

4.  In vivo effects of intravascularly applied Escherichia coli hemolysin: dissociation between induction of granulocytopenia and lethality in monkeys.

Authors:  D Vagts; H P Dienes; P J Barth; H Ronneberger; K D Hungerer; S Bhakdi
Journal:  Med Microbiol Immunol       Date:  1993-03       Impact factor: 3.402

Review 5.  The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives.

Authors:  Travis J Wiles; Matthew A Mulvey
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

6.  Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin.

Authors:  S Bhakdi; E Martin
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

Review 7.  Acylation of Escherichia coli hemolysin: a unique protein lipidation mechanism underlying toxin function.

Authors:  P Stanley; V Koronakis; C Hughes
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

8.  Cytocidal effects of Escherichia coli hemolysin on human T lymphocytes.

Authors:  D Jonas; B Schultheis; C Klas; P H Krammer; S Bhakdi
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Pasteurella haemolytica leukotoxin enhances production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by bovine polymorphonuclear leukocytes.

Authors:  P A Henricks; G J Binkhorst; A A Drijver; F P Nijkamp
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

10.  Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933.

Authors:  H Schmidt; L Beutin; H Karch
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.